FourThought Financial Partners’s AbbVie ABBV Stock Holding History

FourThought Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.62M	Sell	16,628 -612	-4%	-$136K	0.31%	84
2025 Q4	$3.94M	Buy	17,240 +215	+1%	+$49K	0.33%	74
2025 Q3	$3.94M	Sell	17,025 -281	-2%	-$57.2K	0.35%	75
2025 Q2	$3.21M	Sell	17,306 -531	-3%	-$98.7K	0.32%	82
2025 Q1	$3.74M	Sell	17,837 -184	-1%	-$35.8K	0.39%	73
2024 Q4	$3.2M	Buy	+18,021	New	+$3.31M	0.33%	78
2024 Q2	–	Sell	-18,205	Closed	-$3.32M	–	179
2024 Q1	$3.32M	Sell	18,205 -45	-0.2%	-$7.75K	0.38%	66
2023 Q4	$2.83M	Buy	18,250 +33	+0.2%	+$4.81K	0.35%	72
2023 Q3	$2.72M	Buy	18,217 +802	+5%	+$118K	0.38%	67
2023 Q2	$2.35M	Sell	17,415 -380	-2%	-$55.7K	0.31%	82
2023 Q1	$2.84M	Buy	17,795 +30	+0.2%	+$4.59K	0.39%	72
2022 Q4	$2.87M	Buy	+17,765	New	+$2.72M	0.42%	68

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FourThought Financial Partners's ABBV Position: Q1 2026 in Review

FourThought Financial Partners reduced its AbbVie (ABBV) stake by 3.5% in Q1 2026, selling an estimated $136K and leaving 16,628 shares worth $3.62M. The position accounts for 0.31% of the portfolio, ranked #84.

FourThought Financial Partners first reported a position in ABBV in Q4 2022 and has held it in 12 quarters since. The position peaked at $3.94M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

FourThought Financial Partners held 16,628 shares of AbbVie worth $3.62M as of Q1 2026.
FourThought Financial Partners sold 612 AbbVie shares in Q1 2026, an estimated $136K.
AbbVie made up 0.31% of FourThought Financial Partners's portfolio in Q1 2026, its #84 holding.
FourThought Financial Partners first reported a position in AbbVie in Q4 2022 and has held it in 12 quarters since.
FourThought Financial Partners's AbbVie position peaked at $3.94M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.